rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1997-11-7
|
pubmed:abstractText |
The aim of the present study was to estimate the additional radiation exposure to personnel, other patients and members of the family caused by patients who had been injected with 99mTc-Sestamibi (Cardiolite DuPONT PHARMA) for preoperative localization of parathyroid adenoma.
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0029-5566
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
202-4
|
pubmed:dateRevised |
2007-1-12
|
pubmed:meshHeading |
pubmed-meshheading:9380537-Adenoma,
pubmed-meshheading:9380537-Air Pollution, Indoor,
pubmed-meshheading:9380537-Air Pollution, Radioactive,
pubmed-meshheading:9380537-Environmental Exposure,
pubmed-meshheading:9380537-Half-Life,
pubmed-meshheading:9380537-Health Personnel,
pubmed-meshheading:9380537-Humans,
pubmed-meshheading:9380537-Hyperparathyroidism,
pubmed-meshheading:9380537-Inpatients,
pubmed-meshheading:9380537-Male,
pubmed-meshheading:9380537-Occupational Exposure,
pubmed-meshheading:9380537-Parathyroid Neoplasms,
pubmed-meshheading:9380537-Technetium Tc 99m Sestamibi,
pubmed-meshheading:9380537-Visitors to Patients
|
pubmed:year |
1997
|
pubmed:articleTitle |
[How great is radiation exposure in the area surrounding patients after administration ov 99mTc-sestamibi?].
|
pubmed:affiliation |
Universitätsklinik für Nuklearmedizin, Wien, Osterreich. AMIR.KURTARAN@akh-wien.ac.at
|
pubmed:publicationType |
Journal Article,
English Abstract
|